Yes, I follow the drug stocks that've been mentioned here.
Among the big pharma I have shares in ABT, PFE, MRK, BMY, NVS, and JNJ. I'll take more ABT if it hits new lows (drops a few more points)on no adverse news.
For a while I was interested in chemical companies that have a drug component: I gave up on BAY and recently sold my shares at a loss. I've cut back my position in AKZOY.
Of the smaller drug manufacturers, I, like some others here, have ELN, a stock on this thread's FY2004 Double list. This stock has performed very well recently. It's one of those stocks that one might have made huge percentage gains on or taken huge percentage losses on, depending on what year in the past five one bought, and if one sold out or added more at lows. (which I unfortunately, did not)
It's my guess that on this thread, it's been the big pharma that's looked at most when folks are considering drug stocks, and so these are the stocks that are posted on most often here. However, imo, the real story and profits (doubles, triples, etc.) have been in the smaller drug stocks that have been brought forth here, but only occasionally - and with little or no follow-up discussion. Particularly noteworthy are the several drug stocks that sold below cash value (albeit with a burn rate). I am not sure, but it seems that every one of these companies moved up substantially in price in the months or so after they were mentioned here. I am still following some of these stocks.
I also still have stocks ancillary to the drug business. That would be, for example, LH in drug testing (patient diagnosis), KNDL (contract research), a couple medical insurance companies, some medical device companies, and the medical supply companies which we've discussed here.
Paul Senior |
